Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership6,323,752 shares
Latest Disclosed Value $ 1,998,875,417
Jpmorgan Chase & Co ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 6,323,752 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $1,806,695,946 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 4,719,999 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 33.98% during the quarter. The current value of the position is $1,647,337,396 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 12,000 of underlying shares valued at $3,793,080 USD and put options representing 12,000 of underlying shares valued at $3,793,080 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 6,323,752 1,603,753 33.98 1,998,875 6.50 0.0139
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 4,719,999 176,229 3.88 1,876,908 -9.41 0.1178
2025-11-26 2025-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 4,543,770 2,481,762 120.36 2,071,971 208.14 0.1241
2025-11-07 2025-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 4,543,770 2,481,762 2,071,971 0.0131
2025-08-12 2025-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,062,008 -156,864 -7.07 672,410 12.23 0.0440
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,218,872 -31,188 -1.39 599,140 13.16 0.0437
2025-02-12 2024-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,250,060 87,116 4.03 529,462 -11.00 0.0394
2024-12-26 2024-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,162,944 390,073 22.00 594,875 38.08 0.0452
2024-11-08 2024-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,162,944 390,073 594,875 0.0453
2024-12-26 2024-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 1,772,871 24,682 1.41 430,808 64.89 0.0353
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 1,772,871 24,682 430,808 0.0354
2024-12-26 2024-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 1,748,189 -1,267,952 -42.04 261,267 -54.74 0.0221
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 1,748,189 -1,267,952 261,267 0.0221
2024-12-26 2023-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,016,141 -70,705 -2.29 577,320 5.60 0.0554
2024-02-12 2023-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,016,141 -70,705 577,320 0.0555
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,086,846 -46,128 -1.47 546,681 -8.13 0.0603
2023-08-11 2023-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,132,974 38,240 1.24 595,077 -4.01 0.0647
2023-05-18 2023-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,094,734 -32,960 -1.05 619,936 83,336.88 0.0755
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,089,638 -38,056 619,936 0.0092
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 3,127,694 582,662 22.89 743 -99.85 0.0980
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,545,032 261,395 11.45 509,414 52.95 0.0732
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,283,637 -635,378 -21.77 333,069 -30.12 0.0464
2022-05-11 2022-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,919,015 -53,070 -1.79 476,646 -5.43 0.0574
2022-02-11 2021-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,972,085 526,426 21.52 504,007 9.15 0.0582
2022-02-10 2021-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,972,085 526,426 504,007 0.0577
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,445,659 -142,851 -5.52 461,765 5.23 0.0571
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,588,510 410,109 18.83 438,804 42.67 0.0524
2021-05-12 2021-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,178,401 -126,049 -5.47 307,568 2.69 0.0411
2021-02-19 2020-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,304,450 29,185 1.28 299,508 -9.22 0.0440
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,304,450 29,185 299,508 7,407.0463
2020-11-12 2020-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,275,265 52,378 2.36 329,937 0.21 0.0554
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,275,265 329,937
2020-08-11 2020-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 2,222,887 1,380,042 163.74 329,232 258.86 0.0635
2020-05-12 2020-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 842,845 250,331 42.25 91,744 34.45 0.0215
2020-02-11 2019-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 592,514 -55,922 -8.62 68,239 30.86 0.0127
2019-11-12 2019-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 648,436 -16,401 -2.47 52,148 10.35 0.0104
2019-08-07 2019-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 664,837 12,898 1.98 47,256 -22.43 0.0092
2019-05-07 2019-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 651,939 206,129 46.24 60,923 87.43 0.0124
2019-02-11 2018-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 445,810 -540,036 -54.78 32,504 -62.33 0.0075
2018-11-13 2018-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 985,846 352,794 55.73 86,282 38.39 0.0165
2018-11-07 2018-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 985,846 352,794 86,282
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 633,052 577,251 1,034.48 62,348 838.27 0.0128
2018-05-10 2018-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 55,801 42,382 315.84 6,645 289.51 0.0014
2018-02-13 2017-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 13,419 -1,614 -10.74 1,706 -4.05 0.0004
2017-11-09 2017-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 15,033 -40,233 -72.80 1,778 -59.67 0.0004
2017-08-09 2017-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 55,266 -7,720 -12.26 4,409 36.59 0.0010
2017-05-10 2017-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 62,986 6,678 11.86 3,228 53.13 0.0007
2017-02-06 2016-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 56,308 29,712 111.72 2,108 16.92 0.0005
2016-11-04 2016-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 26,596 -4,348 -14.05 1,803 5.01 0.0004
2016-08-08 2016-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 30,944 -7,218 -18.91 1,717 -28.31 0.0004
2016-05-10 2016-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 38,162 450 1.19 2,395 -32.54 0.0006
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 37,712 -116,201 -75.50 3,550 -71.30 0.0009
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 153,913 -138,689 -47.40 12,368 -64.74 0.0033
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 292,602 -233,727 -44.41 35,074 -36.18 0.0083
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 526,329 -122,099 -18.83 54,959 -12.62 0.0125
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 648,428 143,864 28.51 62,898 59.62 0.0144
2014-12-08 2014-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 504,564 -5,289 -1.04 39,406 22.35 0.0093
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 504,564 39,406
2014-09-03 2014-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 509,853 99,216 24.16 32,207 16.81 0.0082
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 509,853 32,207
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 410,637 124,155 43.34 27,571 49.67 0.0076
2014-02-26 2013-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COMMON 02043Q107 286,482 -14,210 -4.73 18,421 -4.30 0.0052
2014-02-13 2013-12-31 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 286,482 18,421
2013-10-31 2013-09-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 300,692 31,105 11.54 19,248 130.32 0.0057
2013-08-13 2013-06-30 13F ALNYLAM PHARMACEUTICALS COMMON 02043Q107 269,587 269,587 8,357 0.0027
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 12,000 -70.00 3,793 -76.15 n/a n/a n/a
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 40,000 3,536.36 15,906 3,074.85 n/a n/a n/a
2025-11-26 2025-09-30 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 1,100 502 n/a n/a n/a
2025-11-07 2025-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 1,100 502 n/a n/a n/a
2025-08-12 2025-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 8,800 2,376 n/a n/a n/a
2024-11-08 2024-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-12-26 2024-06-30 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 22,000 10.00 5,346 78.86 n/a n/a n/a
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 22,000 5,346 n/a n/a n/a
2024-12-26 2024-03-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 20,000 0.00 2,989 -21.92 n/a n/a n/a
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 20,000 2,989 n/a n/a n/a
2024-12-26 2023-12-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 20,000 3,828 n/a n/a n/a
2024-02-12 2023-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 20,000 3,828 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-11 2023-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 7,500 0.00 1,425 -5.19 n/a n/a n/a
2023-05-18 2023-03-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 7,500 1,502 n/a n/a n/a
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 7,500 1,502 n/a n/a n/a
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 12,800 -84.78 2,562 -79.11 n/a n/a n/a
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 84,100 17.95 12,266 5.35 n/a n/a n/a
2022-05-11 2022-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 71,300 -62.96 11,643 -64.33 n/a n/a n/a
2022-02-11 2021-12-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 192,500 32,644 n/a n/a n/a
2022-02-10 2021-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 192,500 32,644 n/a n/a n/a
2021-05-12 2021-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 10,000 1,300 n/a n/a n/a
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 10,000 1,300 n/a n/a n/a
2019-11-12 2019-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-07 2019-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 215,000 15,282 n/a n/a n/a
2019-02-11 2018-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F/A ALNYLAM PHARMACEUTICALS OPTION Call 30,000 11.11 2,626 -1.24 n/a n/a n/a
2018-11-07 2018-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 30,000 2,626 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Call 27,000 0.00 2,659 -17.32 n/a n/a n/a
2018-05-10 2018-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Call 27,000 3,216 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 12,000 -70.00 3,793 -76.15 n/a n/a n/a
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 40,000 1,566.67 15,906 1,353.93 n/a n/a n/a
2025-11-26 2025-09-30 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 2,400 -55.56 1,094 -37.84 n/a n/a n/a
2025-11-07 2025-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 2,400 1,094 n/a n/a n/a
2025-08-12 2025-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 5,400 35.00 1,761 62.96 n/a n/a n/a
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 4,000 1,900.00 1,080 2,197.87 n/a n/a n/a
2025-02-12 2024-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 200 47 n/a n/a n/a
2024-11-08 2024-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-12-26 2024-06-30 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 44,300 -55.92 10,765 -28.33 n/a n/a n/a
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 44,300 10,765 n/a n/a n/a
2024-12-26 2024-03-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 100,500 60.03 15,020 24.95 n/a n/a n/a
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 100,500 15,020 n/a n/a n/a
2024-12-26 2023-12-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 62,800 57.00 12,021 69.68 n/a n/a n/a
2024-02-12 2023-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 62,800 12,021 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 40,000 -20.00 7,084 -25.41 n/a n/a n/a
2023-08-11 2023-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 50,000 0.00 9,497 -5.18 n/a n/a n/a
2023-05-18 2023-03-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 50,000 25.00 10,016 111,188.89 n/a n/a n/a
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 50,000 10,016 n/a n/a n/a
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 40,000 10 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 11,900 2.59 1,736 -8.34 n/a n/a n/a
2022-05-11 2022-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 11,600 -86.07 1,894 -86.59 n/a n/a n/a
2022-02-11 2021-12-31 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 83,300 14,126 n/a n/a n/a
2022-02-10 2021-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 83,300 14,126 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 35,000 5,933 n/a n/a n/a
2020-08-11 2020-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 20,000 2,177 n/a n/a n/a
2019-08-07 2019-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-07 2019-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 18,000 1,682 n/a n/a n/a
2019-02-11 2018-12-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F/A ALNYLAM PHARMACEUTICALS OPTION Put 30,000 11.11 2,626 -1.24 n/a n/a n/a
2018-11-07 2018-09-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 30,000 2,626 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS OPTION Put 27,000 0.00 2,659 -17.32 n/a n/a n/a
2018-05-10 2018-03-31 13F ALNYLAM PHARMACEUTICALS OPTION Put 27,000 3,216 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.